Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study

BACKGROUND: In psoriatic arthritis (PsA), the primary goal of treatment is clinical remission. This study aimed to characterize the molecular profile underlying the induced clinical remission in patients with PsA, comparing the remission state and the healthy condition. METHODS: Whole blood transcri...

Descripción completa

Detalles Bibliográficos
Autores principales: Angioni, Maria Maddalena, Floris, Alberto, Cangemi, Ignazio, Congia, Mattia, Chessa, Elisabetta, Naitza, Micaela Rita, Piga, Matteo, Cauli, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641465/
https://www.ncbi.nlm.nih.gov/pubmed/37965313
http://dx.doi.org/10.3389/fimmu.2023.1274539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641465/
https://www.ncbi.nlm.nih.gov/pubmed/37965313
http://dx.doi.org/10.3389/fimmu.2023.1274539

Ejemplares similares